Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SaudiVax
Jeddah, Makkah, Saudi Arabia
- Ownership
- Private
- Employees
- ~20
- Development stage
- Other
01
Overview
SaudiVax leads Saudi Arabia's local biopharmaceutical manufacturing with a focus on pandemic preparedness, self-sufficiency, and R&D; clinical results have not been disclosed, but collaborations involve monoclonal antibody and vaccine candidates for COVID-19 and other infectious diseases.[1][2][7]
- Therapeutic areas
- Infectious Diseases
- Modalities
- VaccineBiologicMonoclonal antibodyRecombinant proteinSmall molecule
- Industry
- Biotech
02
Partnerships
Aboundbio (US)SONA NanotechnologyMultiple universities (King Saud University, King Fahad Medical Research Centre, KAUST, NIH, University of Pittsburgh, Baylor College of Medicine)
Beyond the preview
Go deeper on SaudiVax.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SaudiVax.